Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alpha-2b and Thalidomide in Disseminated Malignant Melanoma
NCT00026520Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Nov 2001
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide, interferon alfa-2b in melanoma, sponsored by SWOG Cancer Research Network. Started Nov 2001; status: completed.
02
Drugs
thalidomideinterferon alfa-2b
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00026520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00026520.